The New Drugs on the Horizon sessions at AACR Annual Meeting 2025 unveiled 12 novel cancer therapeutics and discussed...
The final day of AACR IO highlighted the emerging frontier of glyco-immunology.
The third keynote session at AACR IO highlighted exciting advances in CAR T-cell therapy, including for solid cancers.
The second keynote session at AACR IO focused on deciphering T-cell receptors, creating TCR libraries, and rewiring cytokine signaling.
To improve cancer outcomes among African Americans, open communication within families and the community is crucial to help break...
Immune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night...
This month, the editors of AACR's journals show their love for studies about CAR T-cell efficacy, breast cancer risk,...
Researchers are examining ways to make treatments more targeted to each type of biliary tract cancer or to each...
Four past recipients of the Global Scholar-in-Training Award (GSITA) share how their experience at the AACR Annual Meeting impacted...
Before a new treatment becomes available for cancer patients, it must be tested in clinical trials and shown to be...
As World Cancer Day 2025 focuses on being "United by Unique," AACR shares how its initiatives help to connect...